Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer’s Disease, Huntington’s Disease and Multiple Sclerosis

Multiple Defects in Energy Metabolism in Alzheimers Disease

(2012) I. L. Ferreira et al.   CURRENT DRUG TARGETS

Label-Free Quantitative Proteomics Analysis of Cotton Leaf Response to Nitric Oxide

(2011) Yanyan Meng et al.   JOURNAL OF PROTEOME RESEARCH

Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses

(2011) Chunbo Zhang et al.   Protein & Cell

Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease

(2010) Jinho Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

(2010) Dimitrios Kapogiannis et al.   LANCET NEUROLOGY

Transcranial brain sonography findings predict disease progression in multiple sclerosis

(2009) U. Walter et al.   NEUROLOGY

Multiple Sclerosis: An Immune or Neurodegenerative Disorder?

(2008) Bruce D. Trapp et al.   Annual Review of Neuroscience

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

(2008) W. S. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteome analysis of human substantia nigra in Parkinson's disease

(2008) Cornelius J Werner et al.   Proteome Science

Experimental and computational approaches to quantitative proteomics: Status quo and outlook

(2007) Alexandre Panchaud et al.   Journal of Proteomics

14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein

(2007) Kazuya Omi et al.   NEUROSCIENCE LETTERS